Cerebral blood flow regulation pathway

The term "Cerebral blood flow regulation pathway" refers not to a single molecule or receptor but rather to a complex set of overlapping physiological and molecular mechanisms that collectively maintain optimal delivery of oxygen and nutrients to the brain. These include myogenic responses (involving vascular smooth muscle cells), metabolic controls (responding to levels of O₂, CO₂, adenosine, H⁺), endothelial signaling (shear stress response), neural factors (autonomic innervation and neurovascular coupling), as well as structural elements like pericytes and astrocytes within the neurovascular unit[1][3][4][6]. These pathways are essential for maintaining cerebral autoregulation—the ability to keep cerebral blood flow relatively constant despite changes in systemic blood pressure. Disruption or dysfunction in these regulatory systems is implicated in various diseases such as stroke, cognitive decline associated with diabetes or aging, neurodegeneration due to impaired clearance mechanisms ("glymphatic system"), and breakdowns in the blood-brain barrier leading to inflammation or neuronal injury[1][3][4]. Pharmacologically, drugs like calcium channel blockers can influence these pathways by reducing vasospasm or stabilizing vascular tone after events such as stroke; however, there is no single drug that targets "the pathway" itself because it comprises multiple cell types and molecular signals rather than a discrete targetable entity[5]. Because "Cerebral blood flow regulation pathway" does not refer specifically to an individual protein/receptor/enzyme/transporter but instead describes an integrated physiological process involving many molecules across several cell types—including ion channels (e.g., L-type Ca²⁺ channels), receptors for vasoactive mediators (e.g., adenosine receptors), tight junction proteins at the BBB—it should not be considered a canonical therapeutic target. Therefore, the entry "Cerebral blood flow regulation pathway" is not a specific molecular target but rather denotes an ensemble of biological processes critical for brain health. It cannot be mapped directly onto standard drug-target databases without further specification.[1][3][4]

Other names

Cerebral blood flow regulatory mechanismsCBF regulation pathwaysNeurovascular coupling pathwaysCerebrovascular autoregulation mechanisms

Modulation of vascular smooth muscle tone via calcium channel inhibition; Alteration of cerebrovascular resistance and perfusion pressure